Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma

Published:2009-01 Issue:4 Volume:48 Page:619-621
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Azad Arun,Herbertson Rebecca A.,Pook David,White Shane,Mitchell Paul L. R.,Tebbutt Niall C.

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860802495362

Reference6 articles.

1. Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus

2. A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma

3. A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: Preliminary results

4. Phase I trial of SU014813 in patients (pts) with advanced solid malignancies

5. Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review;Biomedicines;2023-10-08

2. The clinical features, diagnosis and management of recurrent thymoma;Journal of Cardiothoracic Surgery;2016-08-31

3. Thymoma and thymic carcinomas;Critical Reviews in Oncology/Hematology;2016-03

4. Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors;Annals of Oncology;2015-05

5. Do thymic malignancies respond to target therapies?: Table 1:;Interactive CardioVascular and Thoracic Surgery;2015-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3